Pfizer Inc. (BVMF:PFIZ34)

Market Cap	778.96B
Revenue (ttm)	335.41B
Net Income (ttm)	52.51B
Shares Out	n/a
EPS (ttm)	9.22
PE Ratio	14.83
Forward PE	8.36
Dividend	1.61 (4.71%)
Ex-Dividend Date	Nov 6, 2025

Volume	23,335
Average Volume	12,690
Open	33.64
Previous Close	33.43
Day's Range	33.39 - 34.32
52-Week Range	30.84 - 41.79
Beta	0.43
RSI	53.64
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: PFIZ34

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD